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T he present stud y in vest iga tes the effects of pemphi gus 
lgG and comp lement upon cell viabi lity and /or membrane 
integrit y usin g trypan blue exclusion, ethidium bromide 
(EB) stainin g, and Auo rescein diacetate (FDA) conve rsion 
by li ving cell s. Forty-eight-h our culti v:ltcd epiderm al 
monolayers of neonatal BALB/c mi ce were incubated in 
media contai nin g 1 m g/ ml purified pemphigus lgG for 
48 h in either the presence or absence of co mplement (ab-
sorbed AB se ra). Adherent and detached cells were ex-
amined by both phase and Auorcsccnce microscopy. 
Results from trypan blue exclusion showed that pem-
phigus lgG plus complement produced a modest decrease 
in exclusion of the dye co mpared to pemphigus lgG w ith-
out complement. When FDA/EB co mparisons were made, 
however, the differences were mo re substanti::d. When 
A cantholy sis in pemphig us is generall y thought to be in duced by serum autoantibodies w hi ch react w ith anti gens locJted in the in tercellular substan ce o r o n the surface of epiderm al ce ll s / 1 , 2 /. O th er repo rts suggest that pemph ig us Jn tibodics w ill ind uce acan-
tholyt ic chan ges in cultured skin explants and epiderma l cell s in 
vitro in the absence of complement /3,4 /. and that the pl as min-
ogen-plas min sys tem may be in vo lved in these changes /5 /. O n 
the other hand, Nishika wa et al/ 6 / and Ha shim oto et al/ 7] were 
able to show, by in vitro complement immunofl uorescence (IF) 
sta inin g methods , that so me pemphig us antibod ies w ill fix co m -
plem ent to norm a l human skin . H.ecentl y, we have confirm ed 
and extended these findin gs by demonstratin g that pemphig us 
an tibodies w ill fix co mplement to orga n culture skin explants and 
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Abbreviat ions: 
EB: cthidium bromide 
FDA: Auorcscein diacetate 
IF: immu noAuorescencc 
HBSS: Hanks' ba lanced sa lt so lu tion 
MEM: minimum essentia l medium 
NHS: norma l human serum 
PBS: phosphate-buffered sa li ne 
co mplement plus pemphigus lgG was added to cultures, 
th e nu mber of FDA- positive ad herent cell s decreased sig-
ni fican tl y and the number of EB-positi ve detached ce ll s 
increased signifi ca ntl y. T he effects of co mplement were 
inhi bited by the usc of heat-in activated AB se ra o r by C l q 
depletion of AB sera. N o signifi ca nt effect on the cell s w::1s 
observed in the presence o r absence of co mplement w hen 
pemphigus F(ab'h fragments o r w hen norma l lgG was 
used. Pl as minogen depletion of the co m plemcnt source d id 
no t interfere w ith complement and pemphigus lgG effects 
as judged by the FDA / EB assay. These studies suggest that 
pemphigus antibody in the presence of complement alters 
ce ll membrane integrity :~nd supports the contention that 
co mplement ma y play a s i gni fic:~nt role in the mechanism 
of aca nthol ys is.) In vest Dermatol 86:29-33, 1986 
to L'p id crma l cdlmo no la ycrs in t iss ue culture /8]. We have furthe r 
demonstrated that the add ition of co m plemenr w ill enh ance the 
detachment of ep iderma l cell mono layers induced by pemphigus 
lgG in culture /9], lin kin g complement activa ti on to ep ider m al 
ce ll deta chm ent. 
Si nce co mplement deposits arc rou tinely observed in ea rl y aCJ n-
tho lytic lesion s of pemphig us /1 0- 12 /, and sin ce pemphigus an-
tibodies have clearl y been show n to tlx co mplement com ponents 
to the sur face of epidermal ce lls /8 ], we next w ished to dete rm ine 
w hethe r such complement act ivation wou ld aff<:ct the integ rity 
of the cell m embrane. T he present stu dy was undertaken to in-
vestigate changes in cell membrane integ rity produced by pem-
phi g us J utoa n tibody in the presen ce o r absence of comple m en t 
by the usc of a fluorescein d iacetate (FDA) and cthidium bromide 
(EB) sta inin g method in add ition to the t rypan blue ex clusion 
test. 
MATERIALS AND METHODS 
Epiderntal Keratinocyte Culture Mouse skin from neonata l 
BALB/c mi ce was immersed for 1 h in an antibiotic so lu tion 
co ntainin g 0.1 m g/ml genta mi cin sulf.1tL' (GRS, Garamycin, 
Schering Co., Kenilworth , N ew J ersey), 75 U / ml m ycostatin 
(G ibco Laboratories, Grand Island, N ew York), and 400 IU pen-
icillin-400 J.Lg streptom yci n/ ml in 1-!Jnks' balanced sa lt solu tion 
(H ESS) (Flow Laboratories, M cLean , Virg inia). T he tissue was 
then in cubated in 0.25% tryps in in HBSS at 4°C for 16 h. The 
epide rmis was m echanica ll y separated fro m the dermis and gently 
teased into HESS to separate the cells . T he resu lti ng suspensio n 
was filtered throu g h sterile ga uze and spun at 1000 rpm for 10 
min. The pellet was resuspended in 0.002% DNAasc I (S ig m a 
C he mica l Co.) in calcium-free Medium 199 (Flow Labo rato ries) 
fo r I h at roo m tem perature and su bjected to a discontinuo us 
Perco ll (Phar m acia Fin e C hcm ica ls. In c.) grad ient ( I. 02, l. 04, 
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Table I. Trypan Blue E xclusion Assay (48 h) 
Percent Trypan Blue Excl usion 
Complement Adherent Detached 
Treatn1 cnt'' Cells Cells (N)1' 
Pemphigus lgG NoC 85.4 ± 8.4 36.6 ± 5.7 (4) 
( I mg/ml) c 68.0 ± 7.5 18.9 ± 4. 5 (6) 
C 56°C, 30 min 83 .7 ± 10.8 43.7 ± 10. 1 (2) 
C l q depleted C 84 .9 ± 6.6 30.8 ± 2.0 (7) 
Pemphigus No C 77.3 ± 5.4 32.7 :!: 2.4 (4) 
F(ab ')2 c 71.1 :t 6.5 27.2 :t 4.4 (5) 
(0. 66 mg/ ml) 
Normal lgG No C 79.8 :t 6.6 50.0 :t 4.2 (9) 
(l mg/ ml) c 68. 1 :t 7.5 38.9 ± 5.3 (6) 
No !gG c 78.6 :!: 3.9 37.8 ± 5.7 (2) 
Pcmphi g;us lg;G plus C produced so me decrease in cell viability when compared 
to pemphigus lgG without C. but the diffe rence was significant in only detached 
cells (p < 0.05). 
'
1C: 10°/o nor mal human serum (co mplement source). 
1
'N : The number of tested culture dishes. 
the first tim e directly implicates complem.ent act ivatio n in th e 
pathogenesis o f pemphigus. Sin ce complem ent was shown to 
enhance epiderm al cell detachm ent, we suspected rh;Jt it mi ght 
disrup t cell m embrane integ rity. T o furth er substantiate thi s hy-
po thesis, we chose to use th e combinati on o f FDA and EB in-
trodu ced by Martel ct al [1 9] as a test o f cell membrane integrity. 
N onfluoresccnt FDA is hydrolyzed inside the cells by es terase 
resulting in the release o f fluor escein. T he flu o rescein accumu lates 
in undam aged cells while it leaks o ut o f damaged cell s. In dam aged 
cells, th e EB enters and fo rms a fluorescent orange complex w ith 
th e nuclear DNA. As a result , the cy toplas m of cells w ith intact 
membranes wi ll flu o resce g reen and th e nu clei o f cells w ith dam-
aged m embranes w ill flu oresce o ran ge . T he cy top las m o f cdls 
Wtth EB-positive nuclei do no t flu o resce g reen because the cells 
arc dead or because th e fluoresce in has leaked o ut. 
Whereas no effect on the fluo rescence o f the cells was observed 
w hen I m g/ml pemphi g us lgG w as added to our 48-h cultures 
m the absence of complem ent, w hen complem ent was added to 
such cultures, a signifi cant in crease o f E B-positive deta ched cells 
and a decrease of FDA-positive adherent ce lls w ere apparent . Such 
an effect was inhibited w hen co mplem ent was in activated by 
hea rin g, or w hen the co mplem ent so urce was depleted o f C lq . 
Si milar inhibitio n w as o bserved when pemphigus F(ab' h was 
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used instead of w hole pemphig us lgG . We also o bserved that 
pl as minogen depleti on from the culture sys te m did no t inhibir 
th e change in flu o rescence of cells induced by pemphi gus lgG 
plus complem ent. These res ults suggest th at complem ent acti-
va ted by pemphigus IgG binding to th e cell surface induces altered 
ce ll m embrane integ rity. The la ck o f g reen cy toplasmic fluo res-
cence m ay no t necessa ri ly indi cate cell death; however, prelimi-
nary studies sugges t that the g reen speckles in interm ediate cells 
refl ect th e presence o f liv in g mitochondria . The lack o f FDA-
positive mi tochondria in EB-positive cells m ay be an indi cation 
o f ce ll dea th. 
O ur usc of trypan blu e as an indica to r o f m embrane dam age 
pro ved unsuccess ful. The number o f trypan blue-positi ve cells 
has been sho wn to in crease w ith time and to vary w ith dye co n-
centrati on o r w ith serum concentrati on [20] . M o re recentl y, an 
FDA-propidium io dide m eth od was compared to trypan b lue [21 ] 
w hi ch showed that the FDA-pro pidium iodide m eth od yielded 
m ore consistent results o ver time. T he usc of try pan blue o n eel! 
mono layers rem oved fro m culture with trypsin o r E D T A has 
been repo rted to res ult in g ross ly in accurate and unpredi ctable 
co unts (22]. D ama ged cell s in that stud y w ere no ted to exclude 
cry pan blue. The sli ght elevatio n o f values for adherent EB-pos-
iti ve cells observed by us m ay refl ect the use of trypsin /EDT A 
in th eir rem oval fo r quantitation . T his problem is bein g in ve -
ti ga tcd by us further. 
If the adherent FDA-pos itive cells arc compared to the detach ed 
E B-positive cell s, a very clea r trend is apparent (Ta ble 11) . Pem-
phigus lgG in the presen ce of co mpl em ent results in increase~ 
numbers of cel ls with leaky m em.brancs . If the to tal percent of 
cells in each catego ry (FDA-pos iti ve , E B-positi ve, intermediate) 
detached plus attached are compared , the di fferences arc sti ll sig-
nifi cant (Ta ble Ill). When intermedia te cells w ere added to EB, 
positi vc cells, the co mbined data suppo rted the conclusion thal 
co mp lem ent plus pemphi gus lgG ca uses m embrane dam age tu 
kcratinocy tcs. The hi gh values fo r interm ediate cells occurred it\ 
the adh erent popu lati on with 2 o f the contro ls. Again , these m a 
be the result o f trypsin /E DT A dam age. 
A variety of questio ns concernin g the role complement play1 
in pemphig us rem ain unansw ered . Which compo nents arc in. 
vo lved in the de tachment o f cells, and does co mplem ent enhan 
recruitment of other mediator system s, such as the plasminogen, 
plas min system , and cells , such as eosin o phil s1 Will co mple m en' 
indu ce typi cal m embrane lesions o n the surfaces of epidermal celh 
as observed by e lectron mi crosco py? These, and o th er questiom 
concernin g the in volve m ent o f th e complem ent sys tem in penh 
phigus arc currently under inves ti ga ti on . 
Table II . Fluo rescein Diacetate, E thidiu m B romide Test o f M embrane Integrity: Adherent vs D etached Cells (48 h) 
Complement 
Adh erent Cells (%) Detached Cells (%) 
T rea trn en ti1 Green O range lntenncdiate Green Orange Intermediate (N )h 
Pemphigus lgG No C 65. 2 ± 3.5 15.5 :±: 4.4 7.6 :±: 4. ! 3.2 ± 0.5 10.6 :±: 0.3 2.4 ± 1.2 (3) (l mg/ ml) c 19.4 ± t.O 18.2 :±: 4.9 2.4 :±: 0.9 9.6 ± 1.7 44.3 :±: 8.8 6. 1 :t 2.6 (3) 
C 56°C, 30 min 53.2 :t 3. J 26. 1 :J: 3.9 1.9 :±: 1.1 5.1 :±: 1.6 13.3 :!:: 1. 8 1. 0:!: 0.4 (3) 
C1 q depleted C 45.0 :t 7.8 30.4 :±: 0.2 0.8 :±: 0.5 7. 9 :±: 1. 5 14.8 :J: 0.5 0.9 ± 0.4 (2) 
Pemphigus F(ab'h c 46.8 :t 5.2 21.8 :±: 4.2 2.3 :J: 0. 1 9.0 ± 2.3 17. 1 :J: 3.7 1. 8 ± 0.8 (3) 
(0.66 mg/ml) 
Pbsminogcn-dcpletcd Plasmin ogen- 29.9 :±: 8.1 14.6 ± 2.9 1.6 :±: 0.6 8.7 :±: 1. 0 36.8 ± 6. 1 8.5 ± 4.9 (3) 
pemphigus IgG depleted C 
(l mg/ml) 
Normal IgG No C 62. 6 ± 5.9 19.9 ± 5. 1 2.9 ± 2. 1 5.4 ± 0.3 8.6 ± 0.8 2.3 :J: 1.3 (3) 
(1 mg/ ml) c 58.6±2. 1 23.1 :t 1. 4 1. 8 ± 0.1 5.8 ± 0.7 10.8 ± 0. 7 1.0 :±: 0.4 (3) 
No l gG No C 62.2 ± 4. 2 13.2 :t 2.4 12.0 ± 5.8 3.3 ± 0.6 6.3 ± 0. 7 1. 6 ± 0.5 (4) 
''C: 10% normal human serum (complement source). 
'N : The num ber of rested cultmc dishes. 
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Table III. Fluo rescein D iacctatc, E thidium Bromide Test o f M embrane Integ rity (48 h) 
Co mplement FDA-I'os it; vc EB-I'os iti ve 
EB-I'os iti ve Plus 
Intermediate Intermed iate 
Trc~ltllll'IH Cells(%) Cell s ('X,) Cells(%) Cells ('Yo) (N )'' 
Pemphigus lgG N 9 C 68.4 ± 3.0 26. 1 ± 4.2 10.0 ± 3.4 36. 1 ± 3.9 (3) 
c 29.0 ± 2. 7 62.5 ± 5.5 8.5 ± 3:0 7 1.0 ± 2.8 (3) 
C 56°C, 30 min 58.3 ± 4. ~ 39.4 ± 3.6 2.9 ± 1.1 42.3 ± 4.5 (3) 
C I q dep leted 52.9 ± 2.6 45.2 ± 0.7 1. 7 ± 1.1 46.9 ± 1. 5 (2) 
Pe mphig us c 55.8 ± 6.6 3tl .9 ± 7.6 4. I ± 0 s 43.0 ± 7.2 (3) 
F(a b' )" 
0.66 m g/ml 
Plasm in ogen- Plasminogen- 38.6 ± 7.5 5 1.4 ± 5.8 10. 1 ± 4. 3 6 1. 5 ± 7.5 (3) 
dep le ted depleted C 
pemphigus lgG 
Norm al lgG N o C 68.0 ± 6.2 28.6 ± ~ .9 5.2 ± 3.3 33.8 ± 7.5 (3) 
c 64.4 ± 1. 6 33.9 ± 0.7 2.9 ± 0.2 36.8 ± 0.5 (3) 
No lgG N o C 65.5 ± 4.5 19.6 ± 2.9 13.6 ± 5.9 33. 1 ± 3.9 (4) 
T his J11:dysis o f d_:tt a wa s pcrformc.:d ro gru up _ti ll· r~c ll s i1 ito ~ot~ l J=DA-pos iri vl· c~· ll s (auaci_Jed_ ?Iu s detached) _:llld ro co in pan: th<.·m ro to tal EU-positive (:nr achcd plus 
dcrachnl). ln rcr m ccharc ce ll s :t rc :t lso acco uJll t.: d lo r. I he q u :mnt :HJ VC stud y dc m o nstr:tt cd a slg niii GI.Ilt dccn_·J. sc 111 FDA-positive ce ll s (p < O.Olll ) and :111 in crease in E U-
positi ve cells (p < (I.() I) and Ell-positi ve ce lls plus intermediate cel ls (p < 0.005) w hen CO II>pkmc>H was adckJ to pe mphi g us lgG. 
~: N: The num be r of tcslnl culture dishes. 
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